Texas OK’s $50 Million for Ibogaine Research

Texas is making a bold move by approving $50 million to study ibogaine, a psychedelic substance derived from a West African shrub. The research will focus on its potential to treat PTSD and traumatic brain injuries, particularly in veterans. While ibogaine is illegal in the U.S., this funding signals a growing openness to exploring alternative mental health treatments—despite concerns about safety and regulatory hurdles.